|
CLSN | Imunon, Inc. |
|
|
CLSN | Imunon, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.97 |
| Leverage | 46.36% |
| Market Cap | $ 18.0m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -14.6m |
| Margin | -12713.16% |